These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
268 related items for PubMed ID: 23997103
1. Imatinib attenuates monocrotaline pulmonary hypertension and has potent vasodilator activity in pulmonary and systemic vascular beds in the rat. Pankey EA, Thammasiboon S, Lasker GF, Baber S, Lasky JA, Kadowitz PJ. Am J Physiol Heart Circ Physiol; 2013 Nov 01; 305(9):H1288-96. PubMed ID: 23997103 [Abstract] [Full Text] [Related]
2. Analysis of responses to the Rho-kinase inhibitor Y-27632 in the pulmonary and systemic vascular bed of the rat. Casey DB, Badejo AM, Dhaliwal JS, Sikora JL, Fokin A, Golwala NH, Greco AJ, Murthy SN, Nossaman BD, Hyman AL, Kadowitz PJ. Am J Physiol Heart Circ Physiol; 2010 Jul 01; 299(1):H184-92. PubMed ID: 20435851 [Abstract] [Full Text] [Related]
3. Tyrosine kinase inhibitors are potent acute pulmonary vasodilators in rats. Abe K, Toba M, Alzoubi A, Koubsky K, Ito M, Ota H, Gairhe S, Gerthoffer WT, Fagan KA, McMurtry IF, Oka M. Am J Respir Cell Mol Biol; 2011 Oct 01; 45(4):804-8. PubMed ID: 21378262 [Abstract] [Full Text] [Related]
6. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats. Yang PS, Kim DH, Lee YJ, Lee SE, Kang WJ, Chang HJ, Shin JS. Respir Res; 2014 Nov 25; 15():148. PubMed ID: 25420924 [Abstract] [Full Text] [Related]
8. Delivery of imatinib-incorporated nanoparticles into lungs suppresses the development of monocrotaline-induced pulmonary arterial hypertension. Akagi S, Nakamura K, Miura D, Saito Y, Matsubara H, Ogawa A, Matoba T, Egashira K, Ito H. Int Heart J; 2015 May 13; 56(3):354-9. PubMed ID: 25902888 [Abstract] [Full Text] [Related]
14. Pulmonary and systemic vasodilator responses to the soluble guanylyl cyclase activator, BAY 60-2770, are not dependent on endogenous nitric oxide or reduced heme. Pankey EA, Bhartiya M, Badejo AM, Haider U, Stasch JP, Murthy SN, Nossaman BD, Kadowitz PJ. Am J Physiol Heart Circ Physiol; 2011 Mar 13; 300(3):H792-802. PubMed ID: 21217076 [Abstract] [Full Text] [Related]
20. Iron homeostasis and pulmonary hypertension: iron deficiency leads to pulmonary vascular remodeling in the rat. Cotroneo E, Ashek A, Wang L, Wharton J, Dubois O, Bozorgi S, Busbridge M, Alavian KN, Wilkins MR, Zhao L. Circ Res; 2015 May 08; 116(10):1680-90. PubMed ID: 25767292 [Abstract] [Full Text] [Related] Page: [Next] [New Search]